Data Characteristics
Bioequivalence (BE) regulatory data originates from guidelines, technical review requirements, and regulatory documents published by agencies such as the National Medical Products Administration (NMPA), European Medicines Agency (EMA), and U.S. Food and Drug Administration (FDA), as well as industry standards. These documents typically come in PDF, DOCX, or HTML formats. Update frequency is irregular, usually occurring when regulations are revised or new guidelines are issued. Document structures are rigorous, including chapters, sub-sections, and appendices. Content covers study design, statistical analysis, data submission formats, and waiver conditions. Key fields include drug name, dosage form, strength, reference product information, study type, evaluation indicators (e.g., Cmax, AUC0-t, AUC0-inf), judgment criteria, and statistical analysis methods. Units involve concentration (ng/mL), time (h), and area (ng·h/mL).
Constraints on Workflow Orchestration
The authoritative sources and irregular update cycles of bioequivalence regulatory documents require the data ingestion module in the workflow to support flexible external data source integration and version management. This addresses knowledge base content iteration due to regulatory updates. The rigorous structure and multi-format nature of documents necessitate that the parsing module supports various file types and accurately identifies structured information like chapters, tables, and formulas, ensuring precise knowledge chunking. Given the extensive use of specialized terminology and biostatistical indicators, the RAG (Retrieval-Augmented Generation) module in the workflow needs to be configured with specialized dictionaries and entity recognition capabilities to improve retrieval accuracy. Furthermore, the stringency of regulatory Q&A demands that workflow outputs include traceability, clearly pointing to the source and specific clauses of the original documents, preventing ambiguous or inaccurate answers.
Configuration Settings
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
maxContext | 4096 tokens | Accommodates the length of bioequivalence regulatory clauses, ensuring critical information is fully passed to the model. |
Chunk size | 800-1200 characters | Balances the completeness of knowledge chunks with recall efficiency, avoiding excessive fragmentation or information redundancy. |
Recall count | Top 5 entries | Considering the specialized and interconnected nature of bioequivalence regulations, filters for the most relevant clauses. |
Similarity threshold | 0.75 | Ensures a high level of semantic relevance between retrieval results and user queries, reducing false positives. |
Rerank result count | Top 3 entries | Further optimizes the ranking of retrieval results, prioritizing the most relevant information. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Accommodates the time required for parsing large regulatory files, preventing timeouts during parsing. |
Common Pitfalls
- The AI conversation module in the workflow fails to correctly identify key indicators or judgment criteria in regulatory documents. This manifests as answers lacking specific numerical values or clause numbers. The reason is either overly large or small knowledge chunk granularity, preventing the model from accurately extracting information, or the model not being effectively trained on specialized terminology.
- When users inquire about bioequivalence waiver conditions for specific drugs, the workflow fails to provide accurate applicability or cite relevant clauses. This manifests as vague answers or direct refusal to answer. The reason is insufficient structured data regarding waiver conditions in the knowledge base, or insufficient consideration of contextual information like drug dosage form and strength during retrieval.
- Frequent "tool call failed" or "API request timeout" errors occur during workflow execution. This manifests as conversation interruptions or prolonged unresponsiveness. The reason is concurrency limits or network latency of external APIs (e.g., statistical analysis tools, data query interfaces), causing the workflow to time out while waiting for a response.
Validation Steps
- Select multiple representative bioequivalence regulatory questions, including those involving study design, statistical analysis, and data submission formats. Verify the workflow provides accurate and evidence-based answers.
- Check the accuracy of references to original documents in workflow outputs, including document names, chapter numbers, and specific clauses, to confirm the effectiveness of knowledge traceability.
- Simulate user queries of varying complexity and length. Observe workflow response times and resource utilization to confirm system stability under high load.
- After regulatory updates, re-ingest knowledge and re-test. Ensure the knowledge base update mechanism promptly reflects the latest regulatory requirements and does not affect Q&A accuracy.
The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.